One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa
2018-01-01 Veritti, D; Sarao, V; De Nadai, K; Parmeggiani, F; Lanzetta, P
Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach
2016-01-01 De Maglio, G.; De Pellegrin, A.; Follador, A.; Distefano, S.; Morana, G.; Vailati, P.; Bergamin, N.; Ciani, S.; Poletto, E.; De Carlo, E.; Pelizzari, G.; Cattaneo, M.; Lugatti, E.; Fasola, G.; Pizzolitto, S.
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study
2016-01-01 Lambertini, M.; Pinto, A. C.; Ameye, L.; Jongen, L.; Del Mastro, L.; Puglisi, F.; Poggio, F.; Bonotto, M.; Floris, G.; van Asten, K.; Wildiers, H.; Neven, P.; de Azambuja, E.; Paesmans, M.; Azim, H. A.
Five children with FPIES in one year: Case series
2020-01-01 Valentini, E; Liguoro, I; Saretta, F; Fasoli, L; Cogo, P
Exploratory analyses of candidate predictive and prognostic tissue biomarkers (BMs) in the open-label randomised phase III TANIA trial of bevacizumab (BEV) in HER2-negative locally recurrent/metastatic breast cancer (LR/mBC)
2016-01-01 Zielinski, C.; Gligorov, J.; Marschner, N.; Puglisi, F.; Vrdoljak, E.; Castan, J. C.; de Ducla, S.; Deurloo, R.; Easton, V.; von Minckwitz, G.
Low dose CT scan screening versus empiric surveillance in asbestos exposed subjects: Update of ATOM 002 study
2016-01-01 Fasola, G.; Follador, A.; Barbiero, F.; Rosolen, V.; Belvedere, O.; Grossi, F.; Rossetto, C.; Rizzato, S.; Giavarra, M.; Gerratana, L.; Barbone, F.
Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer?
2017-01-01 Fontanella, C.; Barcellini, A.; Vitale, M. G.; Lepori, S.; Maltese, G.; Tripodi, E.; Cerrotta, A.; Martinelli, F.; Andreetta, C.; Bogani, G.; Ditto, A.; Signorelli, M.; Scaffa, C.; Sacco, C.; Raspagliesi, F.; Lorusso, D.
Absorbing the structural rules in the sequent calculus with additional atomic rules
2019-01-01 Parlamento, F.; Previale, F.
First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma
2016-01-01 De Carlo, E.; Gurrieri, L.; De Maglio, G.; Gerratana, L.; Buoro, V.; Rizzato, S.; Isola, M.; Skrap, M.; Fasola, G.; Puglisi, F.; Pizzolitto, S.
Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition
2018-01-01 Basile, D.; Garattini, S. K.; Pelizzari, G.; Cortiula, F.; Gerratana, L.; Cattaneo, M.; Corvaja, C.; Parnofiello, A.; Andreotti, V. J.; Bertoli, E.; Lisanti, C.; Iacono, D.; Casagrande, M.; Cardellino, G. G.; Miolo, G.; Pella, N.; Aprile, G.; Buonadonna, A.; Fasola, G.; Puglisi, F.
The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer
2018-01-01 Basile, D.; Lisanti, C.; Borghi, M.; Bartoletti, M.; Gerratana, L.; Bortot, L.; Pelizzari, G.; Corvaja, C.; Ongaro, E.; Garattini, S. K.; Fanotto, V.; Parnofiello, A.; Cortiula, F.; Cattaneo, M.; Andreotti, V. J.; Bertoli, E.; Guardascione, M.; Miolo, G.; Puglisi, F.; Buonadonna, A.
The experience of dysgeusia in allogenic hematopoietic cell transplantation survivors: A qualitative study
2018-01-01 Bomben, D.; Bin, A.; Venturini, M.; Bulfone, T.; Ghirotto, L.; Bressan, V.
Laryngectomized patients caregivers' life experience: A phenomenological study
2018-01-01 Bressan, V.; Dri, E.; Stevanin, S.; Cadorin, L.; Rizzuto, A.; Bulfone, G.; Ghirotto, L.
Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario
2018-01-01 Iacono, D.; Vitale, M. G.; Cortiula, F.; Cinausero, M.; Tullio, A.; Valent, F.; Macerelli, M.; Follador, A.; Vogrig, A.; Minisini, A. M.; Puglisi, F.; Fasola, G.
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients
2018-01-01 Pelizzari, G.; Gerratana, L.; Basile, D.; Zago, S.; Vitale, M. G.; Bartoletti, M.; Lisanti, C.; Fanotto, V.; Corvaja, C.; Bortot, L.; Liguori, A.; Cinausero, M.; Russo, S.; Andreetta, C.; Bonotto, M.; Mansutti, M.; Minisini, A. M.; Curcio, F.; Fasola, G.; Puglisi, F.
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer
2018-01-01 Garattini, S. K. K.; Bonotto, M.; Porcu, L.; Ongaro, E.; Basile, D.; Cortiula, F.; Pelizzari, G.; Cattaneo, M.; Parnofiello, A.; Andreotti, V. J.; Corvaja, C.; Cardellino, G. G.; Ermacora, P.; Casagrande, M.; Iacono, D.; Pella, N.; Buonadonna, A.; Minisini, A. M.; Puglisi, F.; Fasola, G.
Comparing nurses' and patients' research priorities in cancer care: A mixed methods systematic review
2018-01-01 Cadorin, L.; Truccolo, I.; Bressan, V.; Suter, N.
Efficacy of retreatment with anti-EGFRs in metastatic colorectal cancer is not predictable by clinical factors related to prior lines of therapy: a multi-institutional analysis
2019-01-01 Rossini, D.; Pagani, F.; Pellino, A.; Dell'Aquila, E.; Liscia, N.; Bensi, M.; Germani, M.; Masi, G.; Moretto, R.; Santini, D.; Salvatore, L.; Scartozzi, M.; Lonardi, S.; Zucchelli, G.; Puglisi, F.; Vannini, F.; Colombo, C.; Falcone, A.; Pietrantonio, F.; Cremolini, C.
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA)
2019-01-01 Basile, D.; Pelizzari, G.; Di Nardo, P.; Corvaja, C.; Ongaro, E.; Garattini, S.; Gerratana, L.; Lisanti, C.; Michele, B.; Bortot, L.; Buriolla, S.; Garutti, M.; Curtolo, G.; Bonotto, M.; Da Ros, L.; Torrisi, E.; Miolo, G.; Cardellino, G.; Pella, N.; Buonadonna, A.; Aprile, G.; Puglisi, F.
KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic non-squamous NSCLC
2019-01-01 Cinausero, M.; Laprovitera, N.; De Maglio, G.; Gerratana, L.; Riefolo, M.; Macerelli, M.; Fiorentino, M.; Porcellini, E.; Buoro, V.; Gelsomino, F.; Squadrilli, A.; Fasola, G.; Tiseo, M.; Ferracin, M.; Ardizzoni, A.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa | 1-gen-2018 | Veritti, D; Sarao, V; De Nadai, K; Parmeggiani, F; Lanzetta, P | |
| Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach | 1-gen-2016 | De Maglio, G.; De Pellegrin, A.; Follador, A.; Distefano, S.; Morana, G.; Vailati, P.; Bergamin, N.; Ciani, S.; Poletto, E.; De Carlo, E.; Pelizzari, G.; Cattaneo, M.; Lugatti, E.; Fasola, G.; Pizzolitto, S. | |
| The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study | 1-gen-2016 | Lambertini, M.; Pinto, A. C.; Ameye, L.; Jongen, L.; Del Mastro, L.; Puglisi, F.; Poggio, F.; Bonotto, M.; Floris, G.; van Asten, K.; Wildiers, H.; Neven, P.; de Azambuja, E.; Paesmans, M.; Azim, H. A. | |
| Five children with FPIES in one year: Case series | 1-gen-2020 | Valentini, E; Liguoro, I; Saretta, F; Fasoli, L; Cogo, P | |
| Exploratory analyses of candidate predictive and prognostic tissue biomarkers (BMs) in the open-label randomised phase III TANIA trial of bevacizumab (BEV) in HER2-negative locally recurrent/metastatic breast cancer (LR/mBC) | 1-gen-2016 | Zielinski, C.; Gligorov, J.; Marschner, N.; Puglisi, F.; Vrdoljak, E.; Castan, J. C.; de Ducla, S.; Deurloo, R.; Easton, V.; von Minckwitz, G. | |
| Low dose CT scan screening versus empiric surveillance in asbestos exposed subjects: Update of ATOM 002 study | 1-gen-2016 | Fasola, G.; Follador, A.; Barbiero, F.; Rosolen, V.; Belvedere, O.; Grossi, F.; Rossetto, C.; Rizzato, S.; Giavarra, M.; Gerratana, L.; Barbone, F. | |
| Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer? | 1-gen-2017 | Fontanella, C.; Barcellini, A.; Vitale, M. G.; Lepori, S.; Maltese, G.; Tripodi, E.; Cerrotta, A.; Martinelli, F.; Andreetta, C.; Bogani, G.; Ditto, A.; Signorelli, M.; Scaffa, C.; Sacco, C.; Raspagliesi, F.; Lorusso, D. | |
| Absorbing the structural rules in the sequent calculus with additional atomic rules | 1-gen-2019 | Parlamento, F.; Previale, F. | |
| First steps in the definition of a prognostic score based on MGMT methylation status in patients with glioblastoma | 1-gen-2016 | De Carlo, E.; Gurrieri, L.; De Maglio, G.; Gerratana, L.; Buoro, V.; Rizzato, S.; Isola, M.; Skrap, M.; Fasola, G.; Puglisi, F.; Pizzolitto, S. | |
| Monocyte-to-lymphocyte ratio in metastatic colorectal cancer: Prognostic role evaluation and cut-off definition | 1-gen-2018 | Basile, D.; Garattini, S. K.; Pelizzari, G.; Cortiula, F.; Gerratana, L.; Cattaneo, M.; Corvaja, C.; Parnofiello, A.; Andreotti, V. J.; Bertoli, E.; Lisanti, C.; Iacono, D.; Casagrande, M.; Cardellino, G. G.; Miolo, G.; Pella, N.; Aprile, G.; Buonadonna, A.; Fasola, G.; Puglisi, F. | |
| The SLICE study: The prognostic role of visceral fat in metastatic colorectal cancer | 1-gen-2018 | Basile, D.; Lisanti, C.; Borghi, M.; Bartoletti, M.; Gerratana, L.; Bortot, L.; Pelizzari, G.; Corvaja, C.; Ongaro, E.; Garattini, S. K.; Fanotto, V.; Parnofiello, A.; Cortiula, F.; Cattaneo, M.; Andreotti, V. J.; Bertoli, E.; Guardascione, M.; Miolo, G.; Puglisi, F.; Buonadonna, A. | |
| The experience of dysgeusia in allogenic hematopoietic cell transplantation survivors: A qualitative study | 1-gen-2018 | Bomben, D.; Bin, A.; Venturini, M.; Bulfone, T.; Ghirotto, L.; Bressan, V. | |
| Laryngectomized patients caregivers' life experience: A phenomenological study | 1-gen-2018 | Bressan, V.; Dri, E.; Stevanin, S.; Cadorin, L.; Rizzuto, A.; Bulfone, G.; Ghirotto, L. | |
| Serum markers as predictors of immune checkpoint inhibitors (ICI) related adverse events in a real-world scenario | 1-gen-2018 | Iacono, D.; Vitale, M. G.; Cortiula, F.; Cinausero, M.; Tullio, A.; Valent, F.; Macerelli, M.; Follador, A.; Vogrig, A.; Minisini, A. M.; Puglisi, F.; Fasola, G. | |
| A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients | 1-gen-2018 | Pelizzari, G.; Gerratana, L.; Basile, D.; Zago, S.; Vitale, M. G.; Bartoletti, M.; Lisanti, C.; Fanotto, V.; Corvaja, C.; Bortot, L.; Liguori, A.; Cinausero, M.; Russo, S.; Andreetta, C.; Bonotto, M.; Mansutti, M.; Minisini, A. M.; Curcio, F.; Fasola, G.; Puglisi, F. | |
| Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer | 1-gen-2018 | Garattini, S. K. K.; Bonotto, M.; Porcu, L.; Ongaro, E.; Basile, D.; Cortiula, F.; Pelizzari, G.; Cattaneo, M.; Parnofiello, A.; Andreotti, V. J.; Corvaja, C.; Cardellino, G. G.; Ermacora, P.; Casagrande, M.; Iacono, D.; Pella, N.; Buonadonna, A.; Minisini, A. M.; Puglisi, F.; Fasola, G. | |
| Comparing nurses' and patients' research priorities in cancer care: A mixed methods systematic review | 1-gen-2018 | Cadorin, L.; Truccolo, I.; Bressan, V.; Suter, N. | |
| Efficacy of retreatment with anti-EGFRs in metastatic colorectal cancer is not predictable by clinical factors related to prior lines of therapy: a multi-institutional analysis | 1-gen-2019 | Rossini, D.; Pagani, F.; Pellino, A.; Dell'Aquila, E.; Liscia, N.; Bensi, M.; Germani, M.; Masi, G.; Moretto, R.; Santini, D.; Salvatore, L.; Scartozzi, M.; Lonardi, S.; Zucchelli, G.; Puglisi, F.; Vannini, F.; Colombo, C.; Falcone, A.; Pietrantonio, F.; Cremolini, C. | |
| The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) | 1-gen-2019 | Basile, D.; Pelizzari, G.; Di Nardo, P.; Corvaja, C.; Ongaro, E.; Garattini, S.; Gerratana, L.; Lisanti, C.; Michele, B.; Bortot, L.; Buriolla, S.; Garutti, M.; Curtolo, G.; Bonotto, M.; Da Ros, L.; Torrisi, E.; Miolo, G.; Cardellino, G.; Pella, N.; Buonadonna, A.; Aprile, G.; Puglisi, F. | |
| KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic non-squamous NSCLC | 1-gen-2019 | Cinausero, M.; Laprovitera, N.; De Maglio, G.; Gerratana, L.; Riefolo, M.; Macerelli, M.; Fiorentino, M.; Porcellini, E.; Buoro, V.; Gelsomino, F.; Squadrilli, A.; Fasola, G.; Tiseo, M.; Ferracin, M.; Ardizzoni, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista1568
Data di pubblicazione
- 2020 - 202598
- 2010 - 2019633
- 2000 - 2009544
- 1990 - 1999234
- 1980 - 198957
- 1978 - 19792
Editore
- Faenza Italy: Gruppo Editoriale F...42
- Mozzon Giuntina SPA:Via Mannelli ...12
- Clinical and Experimental Rheumat...9
- BMJ / British Medical Journal Pub...7
- Elsevier Science Incorporated / N...7
- Roma : Il pensiero scientifico, 2...7
- Edizioni Minerva Medica:Corso Bra...6
- Attuale:ACADEMIC PRESS LTD ELSEVI...5
- -Milano : CLAS international -M...4
- Blackwell Munksgaard:PO Box 2148,...3
Rivista
- EUROPEAN JOURNAL OF PUBLIC HEALTH61
- ITALIAN JOURNAL OF ANATOMY AND EM...55
- ANNALS OF THE RHEUMATIC DISEASES42
- PARAMETRO42
- MINERVA PEDIATRICA37
- INVESTIGATIVE OPHTHALMOLOGY & VIS...35
- BIOCHIMICA CLINICA34
- NEUROLOGICAL SCIENCES34
- ULTRASOUND IN OBSTETRICS & GYNECO...34
- ANNALS OF ONCOLOGY31
Keyword
- Monografia di architetti contempo...9
- Renal microcirculation7
- Endothelin-15
- children4
- Nitric oxide4
- 453 choroid: neovascularization3
- Endothelial function3
- 605 myopia2
- 748 vascular endothelial growth f...2
- Angiotensin II2
Lingua
- eng1051
- ita179
- fre28
- spa1
Accesso al fulltext
- no fulltext1316
- reserved218
- open34